A detailed history of Allworth Financial LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 2,026 shares of CDNA stock, worth $32,294. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,026
Previous 2,050 1.17%
Holding current value
$32,294
Previous $40,000 27.5%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Dec 02, 2025

SELL
$11.57 - $20.63 $277 - $495
-24 Reduced 1.17%
2,026 $29,000
Q2 2025

Aug 07, 2025

BUY
$14.18 - $20.08 $29,069 - $41,164
2,050 New
2,050 $40,000
Q1 2023

Apr 18, 2023

BUY
$8.83 - $17.61 $273 - $545
31 Added 51.67%
91 $0
Q4 2022

Jan 13, 2023

BUY
$10.88 - $20.05 $652 - $1,203
60 New
60 $0
Q2 2022

Jul 13, 2022

BUY
$20.49 - $39.72 $102 - $198
5 New
5 $0
Q3 2020

Nov 03, 2020

SELL
$30.88 - $37.94 $13,896 - $17,073
-450 Closed
0 $0
Q3 2019

Oct 09, 2019

BUY
$20.03 - $40.08 $9,013 - $18,036
450 New
450 $10,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $852M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.